CE Mark
Designed to Enhance the Clinical Value of Red Blood Cells
MicroVascular analysis (MVA)* illustrates the ability of Hemanext ONE RBC** to perfuse networks of artificial capillaries compared to conventionally stored RBC at day 42.1
Hemanext ONE RBC Processing and Storage System
Designed to limit progressive damage to red blood cells during storage.
- Reduces oxygen prior to storage2
- Reduces the accumulation of oxidative and metabolic storage lesions3,4
- Improves quality and function of RBC including deformability4
- Offloads oxygen better than conventional blood5
*Microvascular Analysis (MVA) is an in-vitro model for Research Purposes
** Red Blood Cells
1. Burns et al. Blood Transfus 2016;14:80-8. 2. Hemanext ONE Instructions for Use: 3. D’Alessandro et al. Transfusion 2020;9999:1-13. 4. Yoshida et al. Blood Transfus 2019;17:27-52. 5. Whitley et al. ISBT 2018 [Meeting Abstract].
Send us a Message
ARE YOU A HEALTHCARE PROFESSIONAL?
The information on the page you want access is intended exclusively for healthcare professionals.
No content on that page is intended to provide medical advice or recommend the use of a Hemanext product. Healthcare professionals must always rely on their own professional clinical judgement when using Hemanext products.
Please be aware that Hemanext products may not be commercially available in your country.
By clicking “YES” you confirm that you are a Healthcare professional.